“borderline significance”

Haplotype analysis performed using TRANSMIT showed borderline significance between PKDL and the haplotype AA across −592C/A and −1082A/G (p = 0.053).

These differences were primarily the result of differences between LOC and control group impacts, with impacts leading to LOC associated with higher linear acceleration ( P = 0.004) and rotational acceleration ( P < 0.001), with borderline significance in rotational velocity ( P = 0.053).

Using the ROC-derived optimal cutoff of 1.63 mg/L, high Hs-CRP levels were likewise associated with an elevated mortality risk (HR = 2.090), though the association reached only borderline significance ( p = 0.053). 3.5.

34.77 ± 10.34 kg), with a borderline significance ( p = 0.053).

Among dietary and lifestyle variables, only flavonoid intake showed nominal interaction with GRS ( p = 0.037), while fat intake showed borderline significance ( p = 0.053); neither passed the Bonferroni correction.

The odds of preferring BBN to both parents together among the employed were 1.90 times those of the unemployed (p = 0.98 for the Hosmer-Lemeshow test), but the model had borderline significance (p = 0.053 for the likelihood ratio test).

After 20 weeks, significant between-group differences in the CGIC ( p = 0.001), CDR-SB ( p = 0.032), and CDR Global ( p = 0.037) tests and borderline significance in the ADAS-Cog test ( p = 0.053).

However, only borderline significance was observed with the weighted median method (OR Weighted median = 1.07; 95% CI = 0.99–1.14; p = 0.053) ( Figure 2 and Supplementary Table S5 ).

SNP rs8065080 showed borderline significance in both models (Model I: p = 0.053; Model II: p = 0.066).

Progression‐free survival (PFS) showed slight differences in median time with borderline significance, at 10.2 [8.4–13.5], 9.7 [7.1–13.8], and 8.9 [7.0–12.6] months, respectively ( p = 0.053).

District showed borderline significance ( P = 0.053).

For FLI we found borderline significance (p=0.053) for this age group.

Mean number of emergency department visits were higher for those with depression, with borderline significance (0.51 vs 0.31, p = 0.053).

Whereas the peak CoP ML displacement (DCOP ML-APA ), which was also unaffected by limb condition (p = 0.73), became reduced (by 10%), suggesting participants became cautious, under visual occlusion, though with borderline significance (p = 0.053, ES, 0.46).

Regarding relative changes in d-ROMs levels, the overall group difference showed a borderline significance ( p = 0.053), and the time × group interaction was not significant ( p = 0.159), indicating lower overall postoperative d-ROMs increases but similar temporal trajectories in the POD group ( Figure 3 A).

The addition of CAD-RADS to clinical model showed borderline significance with increasing C-statistic index (0.721 vs. 0.703, p = 0.053).

However, linear regression fit using only this subset of selected biomarkers confirmed a significant predictive value for the 2d‐S100B ( P = 0.009), 2d‐HMGB1 ( P = 0.026), (7d‐2d)‐HBGB1 ( P = 0.001), and (7d‐2d)‐TNF ( P = 0.02), whereas 2d‐TNF had borderline significance ( P = 0.053) and (7d‐2d)‐GFAP was not significant ( P = 0.185).

In case of FBG, individuals with age 35 years and above were found to be at seven fold risk with borderline significance (O.R = 7.46, 95 % C.I. = 0.98–57.28, p = 0.053).

We also observed that oPRL reduced the percentage of lactotropes in G2/M with borderline significance (p = 0.053) ( Fig. 3D ), without other alteration in the progression of the cell cycle in the lactotrope subpopulation ( Fig 3 B, C ).

Metformin daily dose (gram) showed borderline significance (OR = 1.96, 95 % CI: 0.99 to 3.88, P = 0.053).

Chronic kidney disease showed borderline significance with higher long-term mortality in the elderly ( p = 0.053).

The association between RB High and T category showed borderline significance ( P = 0.053).

In addition to the variables with statistical significance, the longer disease duration until IST showed borderline significance with worse response to IST ( P = 0.053), which suggested that earlier intervention of IST to the patients with NS might be beneficial for the attainment of CR.

Regarding CD, HLA‐A*03:01 and A*24:02 reached a borderline significance in negatively affecting the CD of individuals with acute COVID‐19 infection compared to those with sp status ( p = 0.053 and p = 0.06, respectively), while carriers of A*11:01 had significantly decreased CD compared to sp individuals.

This relationship remained significant in the age-adjusted model (Model 1: OR = 3.0, 95% CI = 1.2–7.9; p = 0.025), with a borderline significance for further adjustments for BMI, smoking, physical activity, medication, and supplement use (Model 2: OR 2.6, 95% CI = 1.0–7.0; p = 0.053).